← Open Payments lookup

GEOFFREY XIAO: Open Payments

NPI 1790132017 · TIGARD, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$798 in 44 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $291 · 2025 $798

Food & beverage: $798
CompanyPaymentsAmount
Calliditas Therapeutics US Inc.12$141
AstraZeneca Pharmaceuticals LP5$93
Mallinckrodt Hospital Products Inc.4$79
Novartis Pharmaceuticals Corporation3$54
SCPHARMACEUTICALS INC.2$50
Amgen Inc.2$46
Vifor Pharma, Inc.2$46
Travere Therapeutics, Inc.2$42
Medtronic, Inc.1$36
Otsuka America Pharmaceutical, Inc.2$35

Products named: TARPEYO, ACTHAR, FARXIGA, FUROSCIX, Veltassa, Fabhalta, SYMPLICITY G3, JYNARQUE.

Industry payments across OR — which companies pay providers there.